Infliximab in dermatological treatment: beyond psoriasis

Author： Rigopoulos Dimitris   Korfitis Chrysovalantis   Gregoriou Stamatis   Katsambas Andreas D  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.8, Iss.1, 2008-01, pp. : 123-133

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Infliximab for the treatment of psoriasis

By Kleyn C Elise   Griffiths Christopher EM  

Expert Opinion on Biological Therapy, Vol. 6, Iss. 8, 2006-08 ,pp. : 797-805

Informa Healthcare

Access to resources Recommend Favorite

Infliximab for the treatment of ankylosing spondylitis

By Rudwaleit M   Sieper J  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 8, 2005-08 ,pp. : 1095-1109

Informa Healthcare

Access to resources Recommend Favorite

Infliximab for the treatment of early rheumatoid arthritis

By Geletka Robin C   St Clair E William  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 3, 2005-03 ,pp. : 405-417

Informa Healthcare

Access to resources Recommend Favorite

Psoriasis and its treatment with adalimumab

By Iaconi Ala   Feldman Steven R   Balkrishnan Rajesh  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 1, 2010-01 ,pp. : 133-152

Informa Healthcare

Access to resources Recommend Favorite

Tumor necrosis factor biologics beyond psoriasis in dermatology

By Patel Raj   Cafardi John M   Patel Nital   Sami Naveed   Cafardi Jennifer A  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 10, 2011-10 ,pp. : 1341-1359

Informa Healthcare

Access to resources Recommend Favorite